Neil Almstead
Chief Technical Operations OfficerDr. Neil Almstead Ph.D. serves as Chief Technical Operations Officer since December 2018 and served as an Executive Vice President of Research, Pharmaceutical Operations & Technology of PTC Therapeutics, Inc. since January 2015 to December 2018 and served as its Senior Vice President, Research and CMC from July 2008 to December 2014 and Senior Vice President, Chemistry and CMC from January 2007 to June 2008. Dr. Almstead joined PTC in 2000, from Procter & Gamble (P&G) where he was directly involved in the areas of inflammatory diseases and oncology. At P&G he served as Project leader for both the Matrix Metalloproteinase and Map kinase inhibitor projects. Dr. Almstead has coauthored more than 75 publications and patents pertaining to the design and synthesis of lead candidate compounds for genetic disorders, oncology and inflammatory diseases. Dr. Almstead served as a Postdoctoral Associate at the University of Basel in Switzerland. Dr. Almstead received a B.S. from Clarkson University and a Ph.D. in Organic Chemistry from the University of Illinois at Urbana-Champaign.
Positions
- Company NamePTC Therapeutics, Inc.Stock CodePTCTPositionChief Technical Operations OfficerColleagues
